Remove investor-reveal
article thumbnail

7 investors reveal what’s hot in fintech in Q1 2023

TechCrunch

billion in 2022 from 2021, it was still up 52% compared to 2020 and made up 18% of all funding globally, proving that investors still have faith in fintech’s future. We’re widening our lens, looking for more investors to participate in TechCrunch+ Surveys , where we poll top professionals about challenges in their industry.

advice 110
article thumbnail

The Decline of Small Town Media Has Big Implications for the Innovation Economy

Revolution

Buoyed by that iconic New Mexico experience, we gathered for breakfast alongside local founders, investors, and civic leaders to delve into the city’s expanding innovation landscape. We started the day at sunrise watching hundreds of balloons prepare for one of Albuquerque’s most spectacular events: the mass ascension.

media 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Don’t Make These 5 BIG Mistakes When Answering VC/Customer Questions

Dream It

When pitching a potential investor or customer, time is of the essence. In this Dose, Mike Ravenscroft , Startup Success Manager of Dreamit Healthtech, reveals his top five common mistakes founders make when answering customer and investor questions. For example, an investor asks, “What’s your monthly recurring revenue?”

VC 513
article thumbnail

How To Answer What's Your Valuation?

Dream It

question is a common component of investor Q/A. You need to be aware of and ready for this tough question from investors. In this Dreamit Dose, Managing Director Adam Dakin reveals the right approach on how to answer the valuation question when pitching VCs. The investor just anchored on the lower number.

VC 300
article thumbnail

Virtual Data Rooms: The Unsung Hero of Biotech Financing

Andreessen Horowitz

But how can biotech teams effectively communicate to investors and partners how they will, with each round of financing, incrementally reduce the risks of discovering and developing successful new drugs? These are all common questions you’ll hear from biotech investors. key in vivo data results).

financing 127
article thumbnail

Potential Conflicts of Interest in Proptech

Revolution

Unpacking Proptech: A data-driven series on advancing built world innovation As mentioned in Part 1 , an outsized portion of the proptech investor base comes from the real estate community — a reality I would argue is complicating the industry’s growth. This is largely driven by large investment flows from strategic and tourist investors.

article thumbnail

Reveal raises $50M to espouse the benefits of partner ecosystems

TechCrunch

That’s according to Reveal CEO Simon Bouchez, who alongside Gautier Machelon, Perrine El Khoury, and Alex Sadones aims to build a platform that allows B2B companies to more easily identify sales opportunities with their partners. Image Credits: Reveal. “Users [can] discover new relevant partners across the Reveal network.”